S-1: Natures Miracle Holding Inc. Eyes Public Markets with Unit Offering

Natures Miracle Holding Inc. files for a unit offering comprising common stock and warrants, alongside a resale prospectus for existing shareholders.

Summary

• Natures Miracle Holding Inc. has filed a registration statement for a proposed public offering of units, each containing one share of common stock, a Series A warrant, and a Series B warrant.
• The company is also offering pre-funded units, consisting of a pre-funded warrant and Series A and B warrants, as an alternative for investors who would exceed ownership limits.
• The offering includes registration for the resale of 3,317,400 shares of common stock by existing selling stockholders.
• The company's common stock is listed on The Nasdaq Global Market under the symbol NMHI.
• The closing price of the company's common stock on October 1, 2024, was $0.142 per share.
• The company intends to use the proceeds from this offering for general corporate purposes, including working capital and investments.
• The company generated revenues of approximately $8.9 million in 2023 and incurred a gross loss of approximately $0.9 million.
• In the first six months of 2024, the company generated revenues of approximately $5.6 million and had a gross profit of approximately $0.8 million.
• The company faces a number of risks, including substantial operating losses, competition, and economic uncertainty.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company operates in a growing industry and has shown some revenue growth, the significant losses, going concern doubts, and Nasdaq compliance issues weigh heavily on the sentiment.

Positives

• The company is operating in the growing agriculture technology sector.
• The company has a robust customer base in the U.S. and Canada.
• The company has developed fully automated container-sized units that function as indoor vertical farms.
• Revenue for the three months ended June 30, 2024 increased 75.2% to $3,404,967 as compared to $1,943,528 for the three months ended June 30, 2023.
• Gross profit was $452,220 and $100,271 for the three months ended June 30, 2024 and 2023, respectively.
• The gross margin for the three months ended June 30, 2024 increase to 13.3% from 5.2% for the three months ended June 30, 2023.

Negatives

• The company has incurred substantial operating losses since 2022.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company incurred a gross loss of approximately $0.9 million in 2023.
• The company's projected revenues for 2023 were significantly higher than actual revenue.
• The company relies on a limited number of distributing centers.
• The company typically does not enter into long term contracts with its customers and all the orders are placed on an as-needed base.
• Operating expenses for the three months ended June 30, 2024 increased 279.2% to $1,736,891 as compared to $458,037 for the three months ended June 30, 2023.
• Net loss for the three months ended June 30, 2024 was $1,768,319 as compared to net loss of $406,570 for the three months ended June 30, 2023, representing an increase of $1,361,749.
• Net loss for the six months ended June 30, 2024 was $4,075,125 as compared to net loss of $973,949 for the six months ended June 30, 2023, representing an increase of $3,101,176.
• The company may not be able to continue to satisfy listing requirements of Nasdaq to maintain a listing of our common stock.

Risks

• The company has incurred substantial operating losses since 2022 and there is substantial doubt about its ability to continue as a going concern.
• The company's competitors may develop more effective or commercially attractive products.
• Negative economic conditions could adversely affect the company's business.
• The company's international operations make it susceptible to costs and risks associated with operating internationally.
• The company's limited operating history in the CEA industry makes it difficult to accurately forecast future operating results.
• The company may require additional financing to achieve its business goals.
• The company currently relies on a limited number of distributing centers.
• If product liability lawsuits are brought against the company, it may incur substantial liabilities.
• The company's top suppliers are principally located in regions that are subject to earthquakes and other natural and man-made disasters.
• The company's reliance on a limited base of suppliers for its products may result in disruptions to its business and adversely affect its financial results.
• The company may not be able to adequately obtain, maintain, protect or enforce its intellectual property.
• Certain state and other regulations pertaining to the use of certain ingredients in growing media could adversely impact the company.
• Failure to comply with the United States Foreign Corrupt Practices Act could subject the company to penalties.
• The company may acquire other greenhouses or other indoor farming manufacturing operations, which may divert management's attention and result in additional dilution to stockholders.
• The company's success depends on employing a skilled local labor force, and failure to attract and retain qualified employees could negatively impact its business.
• Damage to the company's reputation or its brand could negatively impact its business.
• The company's actual operating results may differ significantly from its guidance.
• The company qualifies as an emerging growth company, and if it takes advantage of certain exemptions from disclosure requirements, it could make its securities less attractive to investors.
• There is no established public trading market for the Units, Pre-Funded Units, Warrants or Pre-Funded Warrants being offered in this offering.
• The Warrants are speculative in nature.
• Stockholders may experience future dilution as a result of this and future equity offerings.
• The company's stock price may fluctuate significantly.
• If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about the company, its stock price and trading volume could decline.
• The company may not be able to continue to satisfy listing requirements of Nasdaq to maintain a listing of its common stock.
• You will experience immediate and substantial dilution in the net tangible book value per share of the common stock included in the Units.
• If there is no viable public market for the company's common stock, you may be unable to sell your shares at or above your purchase price.
• The company may be subject to securities litigation, which is expensive and could divert management's attention.

Future Outlook

The company expects to continue to grow as it seeks to expand its indoor grower customer base and explore new market opportunities.

Industry Context

The global indoor farming market was estimated at $18.6 billion in 2022, $20.3 billion in 2023 and poised to grow to $32.3 billion in 2028 according to Markets and Markets research.

Management Changes

Legal Proceedings

• Two separate lawsuits were filed against Natures Miracle and two of its wholly-owned subsidiaries by Megaphoton, asserting breach of contract/guarantee agreement.
• Natures Miracle believes that there is no merit in the complaint and has filed a counter-suit against Megaphoton.
• Megaphoton filed requests to dismiss the cases against Hydroman and Visiontech in the Superior Court of Los Angeles.
• The Company was notified of a complaint in San Bernardino Superior Court by Vien Le, its former CFO, who was employed approximately 2 months.
• The lawsuit claims wrongful discharge, untimely payment of wages and other related items.
• The Company has retained counsel and believes it will successfully defend against this lawsuit.

Related Party Transactions

• UniNet Global Inc., a vendor whose stockholder is Zhiyi (Jonathan) Zhang who is also one of the stockholders and management of the Company, sold certain products to Visiontech.
• From 2022 to April 2023, Jinlong (David) Du, the CEO of Megaphoton, was also the Director of the Company and will serve as Director of Natures Miracle following the Merger with Lakeshore.
• On April 11, 2023, one of the Companys customers, Iluminar Lighting LLC (Iluminar) entered into Debt Conversion Agreement with the Company pursuant to which it will convert $1,000,000 of accounts receivable to 1,033,333 shares of Iluminar which is 10% of Iluminars outstanding shares.
• On June 8, 2023, the Company and Lakeshore entered into a promissory note for the principal amount of $40,000 with zero interest rate.
• On July 7, 2023, August 10, 2023, September 11, 2023, Natures Miracle and Lakeshore entered into three promissory notes for the principal amount of $80,000 each with zero interest rate.
• On October 11, 2023 and November 9, 2023, Natures Miracle and Lakeshore entered into two promissory notes pursuant to which Lakeshore borrowed a principal amount of $80,000 each with zero interest rate.
• On December 7, 2023, Natures Miracle and Lakeshore entered into a promissory note pursuant to which Lakeshore borrowed a principal amount of $20,000 with zero interest rate.
• On March 11, 2024, the Company, Lakeshore, RedOne Investment Limited and a prior note holder entered into a Service Fees Letter Agreement, in which the repayment of certain debt in the aggregate amount of $430,000 shall be paid to RedOne Investment Limited.
• On June 14, 2023, in connection with the Newtek Loan Agreement, Natures Miracle, Natures Miracle (California) Inc., a California corporation, Tie (James) Li, Zhiyi Zhang, Upland 858 LLC, a California LLC ( each a Newtek Guarantor, and collectively as the Newtek Guarantors) entered into a commercial guaranty agreement (the Newtek Guaranty) pursuant to which Guarantors guaranteed the payment of the Principal.
• As a consideration for entering into Newtek Guaranty, Tie (James) Li and Zhiyi Zhang each received 50,000 shares of Natures Miracle.

Stakeholder Impact

• Shareholders may experience dilution as a result of this and future equity offerings.
• The company's stock price may fluctuate significantly.
• If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about the company, its stock price and trading volume could decline.
• The company may not be able to continue to satisfy listing requirements of Nasdaq to maintain a listing of its common stock.
• You will experience immediate and substantial dilution in the net tangible book value per share of the common stock included in the Units.
• If there is no viable public market for the company's common stock, you may be unable to sell your shares at or above your purchase price.

Next Steps

• The company intends to monitor the MVPHS Requirement and MVLS Requirement of its common stock and will consider implementing available options to regain compliance with the MVPHS Requirement and MVLS Requirement under the Nasdaq Listing Rules.
• The company intends to monitor the minimum bid price requirement of its common stock and will consider implementing available options to regain compliance with the minimum bid price requirement under the Nasdaq Listing Rules.

Key Dates

Keywords

Natures Miracle Holding Inc., public offering, common stock, warrants, CEA, agriculture technology, indoor farming, controlled environment agriculture, financials, investment